SFRP1 and Miyoshi myopathy: Survival analysis of the 13 genes revealed that high expression levels of CAMK2B, FZD6, PLCB2, PRKACB, RAC2, SFRP1, and WNT1 were associated with improved survival rates, suggesting that the activation of these genes may positively influence MM prognosis.